Samsara BioCapital, L.P.
Insider CIK 1699737 · NGNE 10% owner · VTVT 10% owner · SRRK 10% owner · KLRS 10% owner · GRPH 10% owner · MLYS 10% owner · CRGX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRS Kalaris Therapeutics, Inc. | J Other | 2026-05-20 | 2026-05-22 | 14,937 | — | $0 | 14,937 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | P Buy | 2026-05-20 | 2026-05-22 | 244,300 | $4.83 | $1.18M | 2,224,147 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | J Other | 2026-05-20 | 2026-05-22 | 66,906 | — | $0 | 10,657,028 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | J Other | 2026-05-20 | 2026-05-22 | 4,471 | — | $0 | 19,408 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | P Buy | 2025-12-18 | 2026-02-17 | 479,847 | $10.42 | $5.00M | 1,979,847 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2025-03-13 | 2025-03-17 | 600,000 | $13.50 | $8.10M | 5,674,916 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 20,748 | $24.91 | $516.8K | 1,689,105 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 10,803 | $26.01 | $281.0K | 1,699,908 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 15,219 | $26.73 | $406.8K | 1,715,127 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 2,000 | $27.50 | $55.0K | 1,717,127 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | P Buy | 2024-05-30 | 2024-06-03 | 294,000 | $17.00 | $5.00M | 4,415,689 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-05-22 | 2024-05-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2024-03-05 | 2024-12-06 | 58,885 | — | $0 | 892,578 | SEC↗ |
| VTVT vTv Therapeutics Inc. | J Other | 2024-03-05 | 2024-12-06 | 58,836 | — | $0 | 206,784 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2024-02-12 | 2024-02-14 | 555,555 | $13.50 | $7.50M | 5,074,916 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-16 | 884,400 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-16 | 663,300 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-16 | 1,833,623 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion | 2023-11-14 | 2023-11-16 | 3,381,323 | — | $0 | 3,455,023 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-16 | 666,666 | $15.00 | $10.00M | 4,121,689 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-10-16 | 2023-10-18 | 2,189,781 | $6.85 | $15.00M | 6,788,609 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 2,135,504 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 1,446,357 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-02-14 | 2023-02-16 | 937,500 | $16.00 | $15.00M | 4,519,361 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion | 2023-02-14 | 2023-02-16 | 3,581,861 | — | $0 | 3,581,861 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-04-12 | 2022-04-13 | 350,000 | $4.08 | $1.43M | 8,459,314 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 74,464 | $4.07 | $303.1K | 8,109,314 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-24 | 2022-01-25 | 23,000 | $8.70 | $200.1K | 8,034,850 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-21 | 2022-01-25 | 100,000 | $8.99 | $899.0K | 8,011,850 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-20 | 2022-01-21 | 43,105 | $8.92 | $384.5K | 7,911,850 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-19 | 2022-01-21 | 54,565 | $9.24 | $504.2K | 7,868,745 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-12-15 | 2021-12-20 | 22,329 | $10.19 | $227.5K | 7,814,180 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-11-22 | 2021-11-24 | 201,685 | $10.15 | $2.05M | 7,791,851 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-15 | 2021-10-15 | 2,300 | $12.49 | $28.7K | 7,590,166 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-14 | 2021-10-15 | 3,100 | $12.50 | $38.8K | 7,587,866 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-13 | 2021-10-15 | 45,400 | $13.22 | $600.2K | 7,584,766 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-08 | 2021-10-08 | 75,000 | $13.12 | $984.0K | 7,539,366 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-07 | 2021-10-08 | 9,021 | $14.94 | $134.8K | 7,464,366 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-06 | 2021-10-08 | 61,475 | $13.83 | $850.2K | 7,455,345 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 1,802,372 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 15,000,000 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 55,336 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 741,107 | — | $0 | 6,908,870 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 6,167,763 | — | $0 | 6,167,763 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 22,753 | — | $0 | 22,753 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 485,000 | $17.00 | $8.24M | 7,393,870 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 15,000 | $17.00 | $255.0K | 37,753 | SEC↗ |